General Information of Drug (ID: DMGEMQX)

Drug Name
Anthracen-10-yl(10H-phenothiazin-10-yl)methanone
Synonyms CHEMBL392577; anthracen-10-yl(10H-phenothiazin-10-yl)methanone; BDBM50219206; 10-(9-Anthrylcarbonyl)Phenothiazine; Anthracen-9-yl (10H-phenothiazine-10yl) methanone, 5
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 1 Molecular Weight (mw) 403.5
Logarithm of the Partition Coefficient (xlogp) 7.1
Rotatable Bond Count (rotbonds) 1
Hydrogen Bond Donor Count (hbonddonor) 0
Hydrogen Bond Acceptor Count (hbondacc) 2
Chemical Identifiers
Formula
C27H17NOS
IUPAC Name
anthracen-9-yl(phenothiazin-10-yl)methanone
Canonical SMILES
C1=CC=C2C(=C1)C=C3C=CC=CC3=C2C(=O)N4C5=CC=CC=C5SC6=CC=CC=C64
InChI
InChI=1S/C27H17NOS/c29-27(26-20-11-3-1-9-18(20)17-19-10-2-4-12-21(19)26)28-22-13-5-7-15-24(22)30-25-16-8-6-14-23(25)28/h1-17H
InChIKey
GEDDVJWUHICGPI-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
44435223
ChEBI ID
CHEMBL392577
TTD ID
D00AHD
Drug-Molecule Activity Atlas (DMA)NEW Click to Jump to the Detailed DMA Information of This Drug

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Cholinesterase (BCHE) TTEB0GD CHLE_HUMAN Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Selective reversible inhibition of human butyrylcholinesterase by aryl amide derivatives of phenothiazine. Bioorg Med Chem. 2007 Oct 1;15(19):6367-78.